Sulfanilamide

Sulfanilamide

SCHEMBL9978345

CCOC(N)=O.Nc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfanilamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 16/20 0.57
CA1 P00915 13/20 0.57
CA12 O43570 12/20 0.57
CA9 Q16790 12/20 0.57
CA14 Q9ULX7 5/20 0.57
CA7 P43166 4/20 0.57
CA6 P23280 2/20 0.57
CA5A P35218 2/20 0.57
CA5B Q9Y2D0 2/20 0.57
USP2 O75604 1/20 0.57
TSHR P16473 1/20 0.57
CA4 P22748 1/20 0.57
CA13 Q8N1Q1 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
AGO2 Q9UKV8 1/20 0.57
ALOX15 P16050 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfanilamide SCHEMBL570163 0.80 CA2 (0.68) CA2CA1CA12CA9CA14
Ethyl Benzoate SCHEMBL29187656 0.80 LMNA (0.64) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL28520704 0.80 CA2 (0.74) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL419065 0.80 CA2 (0.74) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL28552204 0.79 CA2 (0.61) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL2215151 0.78 CA2 (0.77) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL20567505 0.78 CA2 (0.77) CA2CA1CA12CA9CA14
Sulfanilamide SCHEMBL28201481 0.78 CA2 (0.85) CA2CA1CA12CA9CA14
Aniline SCHEMBL27371840 0.77 ALOX15 (0.60) TSHRALOX15MEN1KMT2ALMNA
Sulfanilamide SCHEMBL27623151 0.76 CA2 (0.74) CA2CA1CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8779179-B2 Synthesis of silyl acetylenes 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-07-15 US disclosed
US-20130150606-A1 SYNTHESIS OF SILYL ACETYLENES 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-06-13 US disclosed
WO-2011149735-A1 SYNTHESIS OF SILYL ACETYLENES 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150606-A1 SYNTHESIS OF SILYL ACETYLENES TST, ACE, ACE2 CA2 1272/4885CA1 577/4885CA12 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.